| Product Code: ETC10265550 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Rare Diseases Treatment Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Rare Diseases Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 India Rare Diseases Treatment Market - Industry Life Cycle |
3.4 India Rare Diseases Treatment Market - Porter's Five Forces |
3.5 India Rare Diseases Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Rare Diseases Treatment Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 India Rare Diseases Treatment Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 India Rare Diseases Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 India Rare Diseases Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
4 India Rare Diseases Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases in India |
4.2.2 Growing awareness and focus on rare diseases by healthcare professionals |
4.2.3 Advancements in medical research and technology for rare diseases treatment |
4.3 Market Restraints |
4.3.1 High treatment costs and limited access to specialized care |
4.3.2 Lack of infrastructure and resources for rare diseases treatment in certain regions |
5 India Rare Diseases Treatment Market Trends |
6 India Rare Diseases Treatment Market, By Types |
6.1 India Rare Diseases Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Rare Diseases Treatment Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 India Rare Diseases Treatment Market Revenues & Volume, By Small Molecule Drugs, 2021 - 2031F |
6.1.4 India Rare Diseases Treatment Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.1.5 India Rare Diseases Treatment Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.6 India Rare Diseases Treatment Market Revenues & Volume, By Enzyme Replacement, 2021 - 2031F |
6.1.7 India Rare Diseases Treatment Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 India Rare Diseases Treatment Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 India Rare Diseases Treatment Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.2.3 India Rare Diseases Treatment Market Revenues & Volume, By Stem Cell Therapy, 2021 - 2031F |
6.2.4 India Rare Diseases Treatment Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.2.5 India Rare Diseases Treatment Market Revenues & Volume, By Protein Therapy, 2021 - 2031F |
6.2.6 India Rare Diseases Treatment Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 India Rare Diseases Treatment Market, By Disease Type |
6.3.1 Overview and Analysis |
6.3.2 India Rare Diseases Treatment Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.3.3 India Rare Diseases Treatment Market Revenues & Volume, By Neuromuscular Disorders, 2021 - 2031F |
6.3.4 India Rare Diseases Treatment Market Revenues & Volume, By Hematological Disorders, 2021 - 2031F |
6.3.5 India Rare Diseases Treatment Market Revenues & Volume, By Rare Cancers, 2021 - 2031F |
6.3.6 India Rare Diseases Treatment Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 India Rare Diseases Treatment Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Rare Diseases Treatment Market Revenues & Volume, By Hospitals & Clinics, 2021 - 2031F |
6.4.3 India Rare Diseases Treatment Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.4 India Rare Diseases Treatment Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.4.5 India Rare Diseases Treatment Market Revenues & Volume, By Pharma Companies, 2021 - 2031F |
6.4.6 India Rare Diseases Treatment Market Revenues & Volume, By Others, 2021 - 2031F |
6.5 India Rare Diseases Treatment Market, By Drug Type |
6.5.1 Overview and Analysis |
6.5.2 India Rare Diseases Treatment Market Revenues & Volume, By Orphan Drugs, 2021 - 2031F |
6.5.3 India Rare Diseases Treatment Market Revenues & Volume, By Precision Medicine, 2021 - 2031F |
6.5.4 India Rare Diseases Treatment Market Revenues & Volume, By RNA-Based Therapy, 2021 - 2031F |
6.5.5 India Rare Diseases Treatment Market Revenues & Volume, By Recombinant DNA, 2021 - 2031F |
6.5.6 India Rare Diseases Treatment Market Revenues & Volume, By Others, 2021 - 2031F |
7 India Rare Diseases Treatment Market Import-Export Trade Statistics |
7.1 India Rare Diseases Treatment Market Export to Major Countries |
7.2 India Rare Diseases Treatment Market Imports from Major Countries |
8 India Rare Diseases Treatment Market Key Performance Indicators |
8.1 Number of clinical trials conducted for rare diseases treatments in India |
8.2 Adoption rate of new rare disease treatment therapies |
8.3 Funding and investments in rare diseases research and development in India |
9 India Rare Diseases Treatment Market - Opportunity Assessment |
9.1 India Rare Diseases Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Rare Diseases Treatment Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 India Rare Diseases Treatment Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.4 India Rare Diseases Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 India Rare Diseases Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10 India Rare Diseases Treatment Market - Competitive Landscape |
10.1 India Rare Diseases Treatment Market Revenue Share, By Companies, 2024 |
10.2 India Rare Diseases Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here